Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Rhinomed Limited
  6. News
  7. All News
    RNO   AU000000RNO1

RHINOMED LIMITED

(RNO)
End-of-day quote. End-of-day quote Australian Stock Exchange - 10/26
0.31 AUD   0.00%
10/19RHINOMED : New swab takes away children's fear of swabbing
EQ
10/19PRESS RELEASE : New swab takes away children's fear of swabbing
DJ
09/28Rhinomed Limited Auditor Raises 'Going Concern' Doubt
CI
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about RHINOMED LIMITED
10/19RHINOMED : New swab takes away children's fear of swabbing
EQ
10/19PRESS RELEASE : New swab takes away children's fear of swabbing
DJ
09/28Rhinomed Limited Auditor Raises 'Going Concern' Doubt
CI
09/13Rhinomed Limited Appoints Rhinoswab Distributors for Australia and Belgium, the Netherl..
CI
09/10RHINOMED : to Deliver One Million COVID-19 Nasal Swabs to Australia's Victoria Government
MT
09/09Rhinomed Limited Receives an Initial Purchase Order for One Million Rhinoswabs from the..
CI
08/26Rhinomed Limited Announces Ethics Approval Granted for Clinical Trial of First Nasal Sw..
CI
08/26Rhinomed Limited Reports Earnings Results for the Full Year Ended June 30, 2021
CI
08/10Rhinomed Limited Receives Purchase Orders and Begun Supplying NSW Health Pathology
CI
05/20RHINOMED : Receives CE Mark for Nasal Swab Product
MT
05/13Rhinomed Limited Announces the Appointment of Associate Professor John Mcbain AO as A N..
CI
05/13RHINOMED : Nasal Swab Product Achieves High Yields, Clinical Study Reveals
MT
05/12Rhinomed Limited Reports an Important Update on Its Rhinoswabô Clinical Program
CI
04/13RHINOMED : Receives $141,000 R&D Tax Refund
MT
02/23Rhinomed Limited Reports Earnings Results for the Half Year Ended December 31, 2020
CI
02/23CHURCH & DWIGHT : CHPA Welcomes Three Consumer Healthcare Industry Members
AQ
01/28RHINOMED : Revenue Increases 24% in October-December 2020; Shares Fall 7%
MT
2020Rhinomed Limited Detects SARS-CoV-2 in Doherty Inst. RT-PCR Study
CI
2020Innovation Investor Conference Presentations Now Available for On-Demand Viewing
AQ
2020RHINOMED : Registers New Nasal Swab With Australian Therapeutic Goods Administration
MT
2020Rhinomed Limited Announces Registration of Nasal Swab with Australian Therapeutic Goods..
CI
2020RHINOMED : Registers Nasal Swab With US FDA
MT
2020Rhinomed Limited Announces Registration of Its Novel Nasal Swab with the US FDA
CI
2020Live Growth Opportunities Investor Conference October 8th
AQ
2020Rhinomed Limited Auditor Raises 'Going Concern' Doubt
CI
2020Rhinomed Limited Announces Developing New Nasal Swab
CI
2020Rhinomed Limited Reports Earnings Results for the Full Year Ended June 30, 2020
CI
2020Rhinomed Limited Receives Purchase Orders Confirming Major Distribution Expansion of it..
CI
2020RHINOMED LIMITED : RIGHTS ISSUE: 1 new share @ 0.077 AUD for 2 existing shares
FA
2020Rhinomed Limited Appoints Sean Slattery as Company Secretary Replacing Phillip Hains
CI
2020Rhinomed Limited Reaffirms Earning Guidance for Third Quarter of 2020
CI
2020Rhinomed Limited Reports Earnings Results for the Half Year Ended December 31, 2019
CI
2019LIVE INVESTOR CONFERENCE & WEBINAR : A Global Portfolio of OTCQX Consumer and Resources Le..
AQ
2019Rhinomed Limited announced that it has received AUD 6 million in funding
CI
2019Rhinomed Limited Announces Change of Address
CI
2019Rhinomed Limited Reports Earnings Results for the Full Year Ended June 30, 2019
CI
2019Rhinomed Limited's Pronto Technology Receives CE Mark
CI
2019Rhinomed Limited's New Pronto Rechargeable, Vapour Release Technology Registered with U..
CI
2019Rhinomed to Launch Revolutionary New Rechargeable, Vapour Release Technology Targeting ..
CI
2019Rhinomed Limited Reports Earnings Results for the Half Year Ended December 31, 2018
CI
2018Rhinomed Limited announced that it has received AUD 5 million in funding
CI
2018Rhinomed Limited Announces Management Changes
CI
2018Rhinomed Limited announced that it expects to receive AUD 5 million in funding
CI
2018Rhinomed Signs Exclusive Licensing Agreement with Columbia Care LLC for its Nasal Platf..
CI
2018Rhinomed Limited Announces Audited Parent Company Earnings Results for the Year Ended J..
CI
2018Rhinomed Limited Announces Preliminary Consolidated Earnings Results for the Year Ended..
CI
2018Columbia Care, LLC Announces Entered into Licensing Agreement with Rhinomed
CI
2018Rhinomed and Columbia Care LLC to Develop Cannabis Based Medicines
CI
2018Rhinomed Limited Enters into New Distribution Agreement and Receives an Initial Order f..
CI
2018Rhinomed Limited Reports Consolidated Earnings Results for the Half Year Ended December..
CI
2017Rhinomed Limited announced that it has received AUD 3.51 million in funding
CI
2017Rhinomed Limited announced that it expects to receive AUD 3.6 million in funding
CI
2017Rhinomed Limited Announces Resignation of Justyn Stedwell as Joint Company Secretary
CI
2017Rhinomed Limited Announces Wholesale Distribution Agreement with Phoenix Healthcare Dis..
CI
2017Rhinomed Limited Announces Distribution Agreement with Brojaw Inc
CI
2017Rhinomed Limited Announces Unaudited Consolidated Earnings Results for the Year Ended J..
CI
2017Rhinomed Limited Announces Update on Sleep and Breathing Technology
CI
2017Rhinomed Limited Announces Change of Registered Office & Principal Place
CI
2017RHINOMED LTD : REVERSE SPLIT: 1 of 10
FA
2017Rhinomed Ltd Announce GNC USA to Sell Mute
AW
2017Rhinomed Limited Announces Mute to go on Sale in over 800 North American GNC Stores
CI
2017RNO : Notice of General Meeting-Proxy Form
PU
2017RNO : Notification of Consolidation-Split
PU
2017RNO : Appendix 3B
PU
2017RNO : Cleansing Prospectus
PU
2017RNO : Capital Management Initiatives
PU
2017RNO : Rhinomed Receives $280k Research And Development Tax Refund
PU
2017Rhinomed Ltd Adds US Based Cornerstone Investors and Initiates Capital Management Prog..
AW
2017RNO : Rhinomed Completes Successful Capital Raise And Cornerstone Investment
PU
2017Rhinomed Ltd Mute Global Distribution Milestone Update
AW
2017RNO : Mute Global Distribution Milestone Update
PU
2017RNO : Business Update & Appendix 4C
PU
2017RNO : Working Capital Facility
PU
2017Rhinomed Limited Announces Consolidated Earnings Results for the Six Months Ended Decem..
CI
2016Rhinomed Limited Enters into Distribution and Supply Agreement with The Linde Group and..
CI
1  2Next
Upcoming event on RHINOMED LIMITED